Skip to content
The Nexus
DossierENTITY

Alkermes

Coverage of Alkermes in the Nexus archive.

Earliest in view: May 5 · 14:35 UTCMost recent: May 5 · 14:35 UTC
Co-mentioned in this coverage
Vertex Pharmaorganization1Cytokineticsorganization1Viridian Therapeuticsorganization1Modernaorganization1Pfizerorganization1
Recent coverage
  • HEALTHMay 5 · 14:35 UTCSTAT NEWS
    STAT+: Are analysts too quick to gloss over Lilly’s liver case?

    Vertex Pharma reported first-quarter earnings and shelved an early stage therapy for cystic fibrosis due to poor tolerability. Cytokinetics' drug Myqorzo met efficacy goals in a study of genetic heart disease. Viridian Therapeutics announced positive results from a Phase 3 study of its drug elegrobart.

Alkermes · Dossier · The Nexus